ATTUNE PHARMACEUTICALS, INC.

Profile

Company Names

ATTUNE PHARMACEUTICALS, INC.

Addresses

250 WEST 55TH STREET, 34TH FLOOR, NEW YORK, NY 10019

Phone Numbers

1-646-597-6987

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$23,319,984.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-06-15 
$23,319,984.00 
$23,584,679.00 
$264,695.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JASON 
 
BABLAK 
EXECUTIVE OFFICER
THAR PHARMACEUTICALS INC   |  ATTUNE PHARMACEUTICALS, INC.
ANDREW 
 
MCDONALD 
EXECUTIVE OFFICER, DIRECTOR
ATTUNE PHARMACEUTICALS, INC.   |  KNICKERBOCKER PROPERTIES, INC. XXXIII
ADAM 
 
TOMASI 
DIRECTOR
ALLAKOS INC.   |  ATTUNE PHARMACEUTICALS, INC.
RODERICK 
 
WONG 
DIRECTOR
RTW ONSHORE FUND ONE, LP   |  RTW OFFSHORE FUND ONE, LTD.   |  RTW INNOVATION ONSHORE FUND LP   |  ROCKET PHARMACEUTICALS LTD.   |  RTW INNOVATION OFFSHORE FUND LTD   |  ATTUNE PHARMACEUTICALS, INC.   |  RTW SPECIAL PURPOSE FUND I, LLC   |  AVIDITY BIOSCIENCES, INC.   |  RTW SPECIAL PURPOSE FUND II, LLC   |  NIKANG THERAPEUTICS, INC.   |  4010 ROYALTY RIVER CI, LP   |  RTW HEARTBEAT CO-INVEST, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-06-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#